105 related articles for article (PubMed ID: 27239314)
21. Magnitude of foot problems in diabetes in the developing world: a study of 1044 patients.
Jayaprakash P; Bhansali S; Bhansali A; Dutta P; Anantharaman R
Diabet Med; 2009 Sep; 26(9):939-42. PubMed ID: 19719717
[TBL] [Abstract][Full Text] [Related]
22. Statin use and peripheral sensory perception: a pilot study.
West B; Williams CM; Jilbert E; James AM; Haines TP
Somatosens Mot Res; 2014 Jun; 31(2):57-61. PubMed ID: 24219409
[TBL] [Abstract][Full Text] [Related]
23. Temporal changes in the prevalence and associates of foot ulceration in type 2 diabetes: the Fremantle Diabetes Study.
Baba M; Davis WA; Norman PE; Davis TM
J Diabetes Complications; 2015 Apr; 29(3):356-61. PubMed ID: 25670409
[TBL] [Abstract][Full Text] [Related]
24. [A multicenter survey on the diabetic foot and its neuropathy in China].
Lin SD; Lin CJ; Wang AH; Zhao S; Yan L; Wang PH; DU YM; Wang ZJ; Xiao ZH; Ma XY; Chen GC; Zhou YS; Li Q; Bian RW; Mao JP; Xu ZR
Zhonghua Yi Xue Za Zhi; 2007 May; 87(18):1241-4. PubMed ID: 17686256
[TBL] [Abstract][Full Text] [Related]
25. Peripheral sensory neuropathy in type 2 diabetes patients: A case control study in Accra, Ghana.
Yeboah K; Puplampu P; Boima V; Antwi DA; Gyan B; Amoah AGB
J Clin Transl Endocrinol; 2016 Sep; 5():26-31. PubMed ID: 29067231
[TBL] [Abstract][Full Text] [Related]
26. Does this patient with diabetes have large-fiber peripheral neuropathy?
Kanji JN; Anglin RE; Hunt DL; Panju A
JAMA; 2010 Apr; 303(15):1526-32. PubMed ID: 20407062
[TBL] [Abstract][Full Text] [Related]
27. Clinical evaluation of a new device in the assessment of peripheral sensory neuropathy in diabetes.
Bracewell N; Game F; Jeffcoate W; Scammell BE
Diabet Med; 2012 Dec; 29(12):1553-5. PubMed ID: 22672257
[TBL] [Abstract][Full Text] [Related]
28. Preventing and treating foot complications associated with diabetes mellitus.
Bowling FL; Rashid ST; Boulton AJ
Nat Rev Endocrinol; 2015 Oct; 11(10):606-16. PubMed ID: 26284447
[TBL] [Abstract][Full Text] [Related]
29. Shear-reducing insoles to prevent foot ulceration in high-risk diabetic patients.
Lavery LA; LaFontaine J; Higgins KR; Lanctot DR; Constantinides G
Adv Skin Wound Care; 2012 Nov; 25(11):519-24; quiz 525-6. PubMed ID: 23080240
[TBL] [Abstract][Full Text] [Related]
30. Improving vibration perception in a patient with type 2 diabetes and sensory peripheral neuropathy.
Ennion L; Hijmans J
S Afr J Physiother; 2019; 75(1):602. PubMed ID: 31392290
[TBL] [Abstract][Full Text] [Related]
31. Improvement in Protective Sensation: Clinical Evidence From a Randomized Controlled Trial for Treatment of Painful Diabetic Neuropathy With 10 kHz Spinal Cord Stimulation.
Argoff CE; Armstrong DG; Kagan ZB; Jaasma MJ; Bharara M; Bradley K; Caraway DL; Petersen EA;
J Diabetes Sci Technol; 2024 Jan; ():19322968231222271. PubMed ID: 38193426
[TBL] [Abstract][Full Text] [Related]
32. What characteristics are most important in stratifying patients into groups with different risk of diabetic foot ulceration?
Naemi R; Chockalingam N; Lutale JK; Abbas ZG
J Diabetes Investig; 2024 Apr; ():. PubMed ID: 38571302
[TBL] [Abstract][Full Text] [Related]
33. Etiology, pathophysiology and classifications of the diabetic Charcot foot.
Papanas N; Maltezos E
Diabet Foot Ankle; 2013; 4():. PubMed ID: 23705058
[TBL] [Abstract][Full Text] [Related]
34. Absent monofilament sensation in a type 2 diabetic feet.
Cheong J; Alexiadou K; Devendra S
London J Prim Care (Abingdon); 2017 Sep; 9(5):73-76. PubMed ID: 29081839
[TBL] [Abstract][Full Text] [Related]
35. Establishing Differences in Thermographic Patterns between the Various Complications in Diabetic Foot Disease.
Gatt A; Falzon O; Cassar K; Ellul C; Camilleri KP; Gauci J; Mizzi S; Mizzi A; Sturgeon C; Camilleri L; Chockalingam N; Formosa C
Int J Endocrinol; 2018; 2018():9808295. PubMed ID: 29721019
[TBL] [Abstract][Full Text] [Related]
36. Correlation between two-point discrimination with other measures of sensory loss in diabetes mellitus patients.
Periyasamy R; Manivannan M; Narayanamurthy VB
Int J Diabetes Dev Ctries; 2008 Jul; 28(3):71-8. PubMed ID: 19902038
[TBL] [Abstract][Full Text] [Related]
37. Clinical Characteristics of Peripheral Neuropathy in Kenyan Patients with HIV Infection Compared with Patients with Concurrent HIV Infection and Diabetes Mellitus.
Kuka WP; Shah J; Alam U; Shah R; Sokhi DS
Diabetes Ther; 2022 Mar; 13(3):441-451. PubMed ID: 35157232
[TBL] [Abstract][Full Text] [Related]
38. Age-related changes in the tactile pressure sensitivity threshold in the sole of the foot in diabetic patients.
Kimura K; Endo Y
J Phys Ther Sci; 2018 Jul; 30(7):917-920. PubMed ID: 30034098
[TBL] [Abstract][Full Text] [Related]
39. Protein Mediated Oxidative Stress in Patients with Diabetes and its Associated Neuropathy: Correlation with Protein Carbonylation and Disease Activity Markers.
Almogbel E; Rasheed N
J Clin Diagn Res; 2017 Feb; 11(2):BC21-BC25. PubMed ID: 28384853
[TBL] [Abstract][Full Text] [Related]
40. BILATERAL NEUROARTHROPATHY 11 YEARS AFTER SIMULTANEOUS PANCREAS-KIDNEY TRANSPLANT FOR TYPE 1 DIABETES MELLITUS.
Ho S; Giddie J; Dhatariya KK
AACE Clin Case Rep; 2019; 5(4):e259-e262. PubMed ID: 31967048
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
